Ye Leiguang, Wang Hui, Liu Baogang
Department of Pulmonary Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China, 150040.
Tumour Biol. 2016 Jan;37(1):1151-7. doi: 10.1007/s13277-015-3835-y. Epub 2015 Aug 16.
MicroRNAs (miRNAs) are a class of small non-coding RNAs that, when dysregulated, are involved in the initiation and progression of various cancers, including lung cancer, in humans. In the current study, qRT-PCR was performed to measure miR-211 expression in human non-small cell lung cancer (NSCLC) cell lines and tissues. Cell proliferation, cell cycle, colony formation, and invasion were performed to detect the functional role of miR-211 in human NSCLC cell line. We used luciferase reporter assay to find the potential target of miR-211. We found that miR-211 expression was upregulated in human non-small cell lung cancer (NSCLC) cell lines and tissues. The overexpression of miR-211 enhanced NSCLC cell proliferation, colony formation, and invasion. SRC kinase signaling inhibitor 1 (SRCIN1) was identified as a direct target of miR-211. SRCIN1 silencing promoted cell proliferation, and SRCIN1 expression was downregulated in human NSCLC cell lines. Thus, miR-211 may function as an oncogenic miRNA in NSCLC, partly by regulating SRCIN1, and the modulation of miR-211 expression represents a potential strategy for the treatment of NSCLC patients.
微小RNA(miRNA)是一类小的非编码RNA,当发生失调时,它们参与包括肺癌在内的多种人类癌症的发生和发展。在本研究中,采用定量逆转录聚合酶链反应(qRT-PCR)检测人非小细胞肺癌(NSCLC)细胞系和组织中miR-211的表达。进行细胞增殖、细胞周期、集落形成和侵袭实验,以检测miR-211在人NSCLC细胞系中的功能作用。我们使用荧光素酶报告基因检测法来寻找miR-211的潜在靶标。我们发现,miR-211在人非小细胞肺癌(NSCLC)细胞系和组织中的表达上调。miR-211的过表达增强了NSCLC细胞的增殖、集落形成和侵袭能力。SRC激酶信号抑制剂1(SRCIN1)被确定为miR-211的直接靶标。SRCIN1沉默促进细胞增殖,且SRCIN1在人NSCLC细胞系中的表达下调。因此,miR-211可能作为NSCLC中的一种致癌性miRNA发挥作用,部分是通过调节SRCIN1,而对miR-211表达的调节代表了一种治疗NSCLC患者的潜在策略。